Johns Hopkins Aramco Healthcare Experience in Management Of Cancer Patient’s Treatment During COVID -19 Pandemic Lockdown Of Qatif Governorate

Volume 3 - Issue 5

Huda Alsayedahmed¹*, Nafeesa Alfaris², Adil Alkhatti², Samer Abushullaih², Fuad Alghamdi³, Joshua Sharp², Raed Alsharraya², Salam Abughaida², Issam Abduljaber² and Dalal Almuhaisen²

Received: June 23, 2020;   Published: August 03, 2020

DOI: 10.32474/OAJOM.2020.03.000174

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Background: COVID-19 pandemic is a serious ongoing global public health crisis. It significantly impacted healthcare systems ability to deliver effective and timely cancer treatment. Cancer patients are at increased risk of death from corona virus. It is essential to continue the healthcare of cancer-patients who reside in a lockdown-zone. Therefore, redeployment of healthcare resources and strategies is vital.

Objective: To highlight JHAH efforts in initiating a remote cancer-therapy infusion center in a lockdown-zone located in Qatif governorate, Saudi Arabia, during March to April 2020, to ensure the continuation of quality evidence-based oncology treatment to eligible patients in a timely manner.

Methods: JHAH medical staff residing in Qatif, already under lockdown as precautionary measures, was redeployed to work in a contracted private hospital (Al Zahra General Hospital; ZGH). To provide the required treatment for JHAH cancer patient who were banned from exiting the lockdown-zone and receiving cancer-treatment at the oncology centre in Dhahran. Oncology treatment team reviewed treatment protocols for all scheduled cancer patients. Patients had the required laboratory tests in ZGH, ahead of treatment date. If the results were acceptable, treatment orders were released, and pharmacy prepared the medications for next day appointments. Medications were delivered to ZGH in Qatif governorate, where JHAH medical team administered them and provided the appropriate care.

Results: 116 JHAH cancer patients received various treatments safely as planned in ZGH. Despite an ongoing global pandemic, the care delivery efforts of the oncology team at JHAH resulted in a patient satisfaction rate above 92%.

Conclusions: Our experience showed that delivering quality care for cancer patients under lockdown was feasible and successful. A well-established healthcare system with supportive leadership, multidisciplinary teamwork and a passion to provide quality and effective service to cancer patients are essential for continuity of care during a pandemic event.

Keywords: COVID-19 pandemic; Cancer-treatment; Lockdown; Precautionary measures

Abstract| Introduction| Results| Discussion| Conclusions| References|